Collectively, these results demonstrate that TREM-1 inhibition through LP17 treatment effectively mitigates TBI-induced cerebral edema and BBB disruption, improves CBF restoration, and promotes recovery of BBB associated proteins. Here, TREM1 is linked to brain edema.